ArticleJournal of diabetes investigation2020

Potential linkage between dipeptidyl peptidase-4 inhibitor use and the risk of pancreatitis/pancreatic cancer.

Jun Shirakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.